American Heart Association

  87
  0


Final ID: MDP214

Causes of Thirty Day Readmission Following ICD Placement in Heart Failure Patient with Amyloidosis

Abstract Body (Do not enter title and authors here): Background and Objectives:
Data regarding readmission rate following ICD placement in heart failure patients with Cardiac amyloidosis are scare. We attempted to study 30-day readmission rate following ICD placement in these patients and the common causes of readmission.

Methods:
We utilized the Nationwide Readmission Database from 2016 to 2020 and included patients more than 18 years of age who were admitted for placement of Implantable Cardiac Defibrillator (ICD) and had secondary diagnosis of heart failure and amyloidosis. We used International Classification of Disease, Tenth Revision, Clinical Modification (ICD10 CM) codes to identify patients. The primary outcome was the 30-day readmission rate, and secondary outcomes were mortality rates, and common reasons for readmission.

Results:
We identified a total of 457 patients who underwent placement of ICD and had heart failure with amyloidosis, among which mean age was 69 years and 25.42% were females. The 30-day readmission rate was 19.50%. Mortality rate was higher in readmitted patients (7.12%) as compared to index admission (3.82%). Most common causes of readmission were hypertension and heart failure with CKD stage 1 to 4(22%), hypertensive heart disease with heart failure (8.35%), hypertensive heart disease with CKD 5 or ESRD (7.58%), Acute Kidney Injury (5.94%), Non-specific chest pain (5.56%), Organ specific amyloidosis (5.43%), Cellulitis (3.68%), Acute on chronic systolic heart failure (3.56%), and Acute systolic heart failure (3.17%)

Conclusion:
The thirty-day readmission rate was 19.50% and most common cause of readmission was hypertension and heart failure with CKD. Improvement of management strategies is needed to address these causes and improve patient outcomes.
  • Jha, Vivek  ( John H Stroger Jr Hospital , Chicago , Illinois , United States )
  • Aryal, Badri  ( John H Stroger Jr Hospital , Chicago , Illinois , United States )
  • Teaima, Taha  ( John H Stroger Jr Hospital , Chicago , Illinois , United States )
  • Quevedo Ramirez, Andres  ( John H Stroger Jr Hospital , Chicago , Illinois , United States )
  • Aziz, Imran  ( John H Stroger Jr Hospital , Chicago , Illinois , United States )
  • Gajjar, Rohan  ( John H Stroger Jr Hospital , Chicago , Illinois , United States )
  • Author Disclosures:
    Vivek Jha: DO NOT have relevant financial relationships | Badri Aryal: DO NOT have relevant financial relationships | Taha Teaima: No Answer | Andres Quevedo Ramirez: DO NOT have relevant financial relationships | IMRAN AZIZ: No Answer | Rohan Gajjar: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Move to the Beat: Updates on Pacing in Heart Failure

Saturday, 11/16/2024 , 12:50PM - 02:15PM

Moderated Digital Poster Session

More abstracts on this topic:
Clinical outcomes of cardiac synchronization with or without an implantable cardioverter defibrillator based on pooled data from 5 clinical trials: a patient-level meta-analysis

Shadrin Ilya, Kutyifa Valentina, Linde Cecilia, Young James, Tang Anthony, Al-khatib Sana, Inoue Lurdes, Schmidler Gillian, Mackenzie Michael, Friedman Daniel, Abraham William, Cleland John, Curtis Anne, Gold Michael

AI-enabled multimodal risk stratification of probable transthyretin amyloid cardiomyopathy from point-of-care electrocardiography and ultrasound: A report from the TRACE-AI Study

Oikonomou Evangelos, Sangha Veer, Dhingra Lovedeep, Aminorroaya Arya, Pedroso Aline, Coppi Andreas, Miller Edward, Gallegos Cesia, Khera Rohan

You have to be authorized to contact abstract author. Please, Login
Not Available